Company page

Sqz Biotechnologies Company

Sqz Biotechnologies Company, trading under the ticker SQZB, operates in the American market with a market capitalization of approximately $707.8 million. The company focuses on developing innovative cell therapy solutions aimed at treating various diseases. Sqz Biotechnologies is committed to advancing its technology to improve patient outcomes and address unmet medical needs.